China Influenza Vaccine Market Research Report 2018

March 2018 | 110 pages | ID: C8D6DC37CF6EN
QYResearch

Abstracts

The global Influenza Vaccine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Influenza Vaccine development status and future trend in China, focuses on top players in China, also splits Influenza Vaccine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• GSK
• Sinovac
• Changsheng
• CCBIO
• Aleph Biomedical
• Sanofi
• Lanzhou Institute Of Biological Product
• Siobp
• Hualan Bio
• Tianyuan Bio-Pharma
• Vaxtec
• Hissen
• Abbott
• Novartis
• Tasly&Jenner
• Tiantan

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into

• Trivalent Influenza Vaccine
• Quadrivalent Influenza Vaccine
• Other

On the basis of the end users/application, this report covers

• Children
• Adults
• Elderly
• Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Influenza Vaccine Market Research Report 2018

1 INFLUENZA VACCINE OVERVIEW

1.1 Product Overview and Scope of Influenza Vaccine
1.2 Classification of Influenza Vaccine by Product Category
  1.2.1 China Influenza Vaccine Sales (K Doses) Comparison by Type (2013-2025)
  1.2.2 China Influenza Vaccine Sales (K Doses) Market Share by Type in 2017
  1.2.3 Trivalent Influenza Vaccine
  1.2.4 Quadrivalent Influenza Vaccine
  1.2.5 Other
1.3 China Influenza Vaccine Market by Application/End Users
  1.3.1 China Influenza Vaccine Sales (K Doses) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Children
  1.3.3 Adults
  1.3.4 Elderly
  1.3.5 Pregnancy
1.4 China Influenza Vaccine Market by Region
  1.4.1 China Influenza Vaccine Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Influenza Vaccine Status and Prospect (2013-2025)
  1.4.3 East China Influenza Vaccine Status and Prospect (2013-2025)
  1.4.4 Southwest China Influenza Vaccine Status and Prospect (2013-2025)
  1.4.5 Northeast China Influenza Vaccine Status and Prospect (2013-2025)
  1.4.6 North China Influenza Vaccine Status and Prospect (2013-2025)
  1.4.7 Central China Influenza Vaccine Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Influenza Vaccine (2013-2025)
  1.5.1 China Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2025)
  1.5.2 China Influenza Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA INFLUENZA VACCINE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Influenza Vaccine Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Influenza Vaccine Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Influenza Vaccine Average Price (USD/Dose) by Players/Manufacturers (2013-2018)
2.4 China Influenza Vaccine Market Competitive Situation and Trends
  2.4.1 China Influenza Vaccine Market Concentration Rate
  2.4.2 China Influenza Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA INFLUENZA VACCINE SALES AND REVENUE BY REGION (2013-2018)

3.1 China Influenza Vaccine Sales (K Doses) and Market Share by Region (2013-2018)
3.2 China Influenza Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Influenza Vaccine Price (USD/Dose) by Regions (2013-2018)

4 CHINA INFLUENZA VACCINE SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Influenza Vaccine Sales (K Doses) and Market Share by Type/ Product Category (2013-2018)
4.2 China Influenza Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Influenza Vaccine Price (USD/Dose) by Type (2013-2018)
4.4 China Influenza Vaccine Sales Growth Rate (%) by Type (2013-2018)

5 CHINA INFLUENZA VACCINE SALES BY APPLICATION (2013-2018)

5.1 China Influenza Vaccine Sales (K Doses) and Market Share by Application (2013-2018)
5.2 China Influenza Vaccine Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA INFLUENZA VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Influenza Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Sinovac
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Influenza Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sinovac Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Changsheng
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Influenza Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Changsheng Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 CCBIO
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Influenza Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CCBIO Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Aleph Biomedical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Influenza Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aleph Biomedical Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Influenza Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Lanzhou Institute Of Biological Product
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Influenza Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Siobp
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Influenza Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Siobp Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Hualan Bio
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Influenza Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Hualan Bio Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Tianyuan Bio-Pharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Influenza Vaccine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Vaxtec
6.12 Hissen
6.13 Abbott
6.14 Novartis
6.15 Tasly&Jenner
6.16 Tiantan

7 INFLUENZA VACCINE MANUFACTURING COST ANALYSIS

7.1 Influenza Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Influenza Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA INFLUENZA VACCINE MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Influenza Vaccine Sales (K Doses), Revenue (Million USD) Forecast (2018-2025)
11.2 China Influenza Vaccine Sales (K Doses) Forecast by Type (2018-2025)
11.3 China Influenza Vaccine Sales (K Doses) Forecast by Application (2018-2025)
11.4 China Influenza Vaccine Sales (K Doses) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Influenza Vaccine Sales (K Doses) and Revenue (Million USD) Market Split by Product Type
Table Influenza Vaccine Sales (K Doses) by Application (2013-2025)
Figure Product Picture of Influenza Vaccine
Table China Influenza Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Influenza Vaccine Sales Volume Market Share by Types in 2017
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure China Influenza Vaccine Sales (K Doses) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Influenza Vaccine by Application in 2017
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure South China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2025)
Figure China Influenza Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Influenza Vaccine Sales of Key Players/Manufacturers (2013-2018)
Table China Influenza Vaccine Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Influenza Vaccine Sales Share (%) by Players/Manufacturers
Figure 2017 China Influenza Vaccine Sales Share (%) by Players/Manufacturers
Table China Influenza Vaccine Revenue by Players/Manufacturers (2013-2018)
Table China Influenza Vaccine Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Influenza Vaccine Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Influenza Vaccine Revenue Market Share (%) by Players/Manufacturers
Table China Market Influenza Vaccine Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Influenza Vaccine Average Price of Key Players/Manufacturers in 2017
Figure China Influenza Vaccine Market Share of Top 3 Players/Manufacturers
Figure China Influenza Vaccine Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Influenza Vaccine Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Influenza Vaccine Product Category
Table China Influenza Vaccine Sales (K Doses) by Regions (2013-2018)
Table China Influenza Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Influenza Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Influenza Vaccine Sales Market Share (%) by Regions in 2017
Table China Influenza Vaccine Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Influenza Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Influenza Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Influenza Vaccine Revenue Market Share (%) by Regions in 2017
Table China Influenza Vaccine Price (USD/Dose) by Regions (2013-2018)
Table China Influenza Vaccine Sales (K Doses) by Type (2013-2018)
Table China Influenza Vaccine Sales Share (%) by Type (2013-2018)
Figure China Influenza Vaccine Sales Share (%) by Type (2013-2018)
Figure China Influenza Vaccine Sales Market Share (%) by Type in 2017
Table China Influenza Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Influenza Vaccine Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Influenza Vaccine by Type (2013-2018)
Figure Revenue Market Share of Influenza Vaccine by Type in 2017
Table China Influenza Vaccine Price (USD/Dose) by Types (2013-2018)
Figure China Influenza Vaccine Sales Growth Rate (%) by Type (2013-2018)
Table China Influenza Vaccine Sales (K Doses) by Applications (2013-2018)
Table China Influenza Vaccine Sales Market Share (%) by Applications (2013-2018)
Figure China Influenza Vaccine Sales Market Share (%) by Application (2013-2018)
Figure China Influenza Vaccine Sales Market Share (%) by Application in 2017
Table China Influenza Vaccine Sales Growth Rate (%) by Application (2013-2018)
Figure China Influenza Vaccine Sales Growth Rate (%) by Application (2013-2018)
Table GSK Influenza Vaccine Basic Information List
Table GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure GSK Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure GSK Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure GSK Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Sinovac Influenza Vaccine Basic Information List
Table Sinovac Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Sinovac Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Sinovac Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Sinovac Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Changsheng Influenza Vaccine Basic Information List
Table Changsheng Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Changsheng Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Changsheng Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Changsheng Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table CCBIO Influenza Vaccine Basic Information List
Table CCBIO Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure CCBIO Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure CCBIO Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure CCBIO Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Aleph Biomedical Influenza Vaccine Basic Information List
Table Aleph Biomedical Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Aleph Biomedical Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Aleph Biomedical Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Aleph Biomedical Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Sanofi Influenza Vaccine Basic Information List
Table Sanofi Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Sanofi Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Sanofi Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Sanofi Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Lanzhou Institute Of Biological Product Influenza Vaccine Basic Information List
Table Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Siobp Influenza Vaccine Basic Information List
Table Siobp Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Siobp Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Siobp Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Siobp Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Hualan Bio Influenza Vaccine Basic Information List
Table Hualan Bio Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Hualan Bio Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Hualan Bio Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Hualan Bio Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Tianyuan Bio-Pharma Influenza Vaccine Basic Information List
Table Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales Market Share (%) in China (2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Revenue Market Share (%) in China (2013-2018)
Table Vaxtec Influenza Vaccine Basic Information List
Table Hissen Influenza Vaccine Basic Information List
Table Abbott Influenza Vaccine Basic Information List
Table Novartis Influenza Vaccine Basic Information List
Table Tasly&Jenner Influenza Vaccine Basic Information List
Table Tiantan Influenza Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Vaccine
Figure Manufacturing Process Analysis of Influenza Vaccine
Figure Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Influenza Vaccine Major Players/Manufacturers in 2017
Table Major Buyers of Influenza Vaccine
Table Distributors/Traders List
Figure China Influenza Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure China Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Influenza Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table China Influenza Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure China Influenza Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure China Influenza Vaccine Sales Volume Market Share Forecast by Type in 2025
Table China Influenza Vaccine Sales (K Doses) Forecast by Application (2018-2025)
Figure China Influenza Vaccine Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Influenza Vaccine Sales Volume Market Share Forecast by Application in 2025
Table China Influenza Vaccine Sales (K Doses) Forecast by Regions (2018-2025)
Table China Influenza Vaccine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Influenza Vaccine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Influenza Vaccine Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources